Historical epidemiology of hepatitis C virus in select countries—volume 4

A. Maaroufi, A. Vince, S. M. Himatt, R. Mohamed, J. Fung, O. Opare-Sem, A. Workneh, R. Njouom, I. Al ghazzawi, M. Abdulla, K. S. Kaliaskarova, S. Owusu-Ofori, M. K. Abdelmageed, D. Adda, O. Akin, A. Al Baqali, N. Al Dweik, K. Al Ejji, S. Al Kaabi, K. Al NaamaniJ. Al Qamish, M. Al Sadadi, J. Al Salman, M. AlBadri, S. A. Al-Busafi, H. E. Al-Romaihi, W. Ampofo, K. Antonov, C. Anyaike, F. Arome, A. Bane, S. Blach, M. M. Borodo, S. M. Brandon, B. Bright, M. T. Butt, I. Cardenas, H. L.Y. Chan, C. J. Chen, D. S. Chen, P. J. Chen, R. N. Chien, W. L. Chuang, D. Cuellar, M. Derbala, A. A. Elbardiny, C. Estes, E. Farag, I. Gamkrelidze, V. Garcia, J. Genov, Z. Ghandour, M. Ghuloom, B. Gomez, J. Gunter, J. Habeeb, O. Hajelssedig, W. Hamoudi, I. Hrstic, C. C. Hu, C. F. Huang, Y. T. Hui, R. Jahis, D. Jelev, A. K. John, Y. Kamel, J. H. Kao, J. Khamis, H. Khattabi, I. Khoudri, A. Konysbekova, I. Kotzev, M. S. Lai, W. C. Lao, J. Layden, M. H. Lee, O. Lesi, M. Li, A. Lo, C. K. Loo, B. Lukšić, A. O. Malu, L. Mateva, R. Mitova, M. Morović, K. Murphy, B. Mustapha, H. Nde, A. Nersesov, E. Ngige, O. Njoya, D. Nonković, S. Obekpa, S. Oguche, E. E. Okolo, O. Omede, C. Omuemu, P. Ondoa, R. O. Phillips, Y. N. Prokopenko, H. Razavi, D. Razavi-Shearer, B. Redae, T. Reic, T. Rinke de Wit, C. Rios, S. Robbins, L. R. Roberts, S. J. Sanad, J. D. Schmelzer, M. Sharma, M. Simonova, T. H. Su, K. Sultan, S. S. Tan, K. Tchernev, O. T.Y. Tsang, S. Tsang, C. Tzeuton, S. Ugoeze, B. Uzochukwu, R. Vi, H. U. Wani, V. W.S. Wong, R. Yacoub, K. I. Yesmembetov, M. Youbi, M. F. Yuen, K. Razavi-Shearer

نتاج البحث: المساهمة في مجلةArticleمراجعة النظراء

28 اقتباسات (Scopus)

ملخص

Due to the introduction of newer, more efficacious treatment options, there is a pressing need for policy makers and public health officials to develop or adapt national hepatitis C virus (HCV) control strategies to the changing epidemiological landscape. To do so, detailed, country-specific data are needed to characterize the burden of chronic HCV infection. In this study of 17 countries, a literature review of published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates was conducted, and inputs were validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Hong Kong to 2.4% in Taiwan, while the largest viraemic populations were in Nigeria (2 597 000 cases) and Taiwan (569 000 cases). Diagnosis, treatment and liver transplant rates varied widely across the countries included in this analysis, as did the availability of reliable data. Addressing data gaps will be critical for the development of future strategies to manage and minimize the disease burden of hepatitis C.

اللغة الأصليةEnglish
الصفحات (من إلى)8-24
عدد الصفحات17
دوريةJournal of Viral Hepatitis
مستوى الصوت24
المعرِّفات الرقمية للأشياء
حالة النشرPublished - أكتوبر 2017

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2721???
  • ???subjectarea.asjc.2700.2725???
  • ???subjectarea.asjc.2400.2406???

بصمة

أدرس بدقة موضوعات البحث “Historical epidemiology of hepatitis C virus in select countries—volume 4'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا